Literature DB >> 2221857

In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs.

V McDonald1, R Stables, D C Warhurst, M R Barer, D A Blewett, H D Chapman, G M Connolly, P L Chiodini, K P McAdam.   

Abstract

Sporozoites of Cryptosporidium parvum which were excysted in vitro from oocysts isolated from calves or patients with acquired immune deficiency syndrome underwent development in monolayers of the mouse fibroblast cell line L929. Asexual multiplication occurred, with the maximum numbers of parasites usually being observed between 24 and 48 h after infection. Gametocytes were also found, but their numbers were relatively small compared with those of the asexual stages. A study was made of the effect on parasite development of 20 antimicrobial agents, most of which were anticoccidial or antimalarial agents. The majority of the drugs had a limited inhibitory effect on parasite development, but usually only at high concentrations. The two most active drugs were monensin and halofuginone, which reduced parasite multiplication by more than 90% at high concentrations. In the case of monensin, however, inhibition of parasite development at higher concentrations was due, at least in part, to a toxic effect of the drug on the host cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221857      PMCID: PMC171859          DOI: 10.1128/AAC.34.8.1498

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

Review 1.  Cryptosporidium spp. and cryptosporidiosis.

Authors:  R Fayer; B L Ungar
Journal:  Microbiol Rev       Date:  1986-12

2.  Attempted chemoprophylaxis of cryptosporidiosis in calves.

Authors:  H W Moon; G N Woode; F A Ahrens
Journal:  Vet Rec       Date:  1982-02-20       Impact factor: 2.695

3.  Experimental cryptosporidiosis in laboratory mice.

Authors:  D Sherwood; K W Angus; D R Snodgrass; S Tzipori
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

4.  The therapeutic effect of 16 antimicrobial agents on Cryptosporidium infection in mice.

Authors:  S R Tzipori; I Campbell; K W Angus
Journal:  Aust J Exp Biol Med Sci       Date:  1982-04

5.  Complete development of Cryptosporidium in cell culture.

Authors:  W L Current; T B Haynes
Journal:  Science       Date:  1984-05-11       Impact factor: 47.728

6.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

7.  Characterization of cyclophosphamide-rat model of cryptosporidiosis.

Authors:  J E Rehg; M L Hancock; D B Woodmansee
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

8.  Cryptosporidial diarrhoea in AIDS and its treatment.

Authors:  G M Connolly; M S Dryden; D C Shanson; B G Gazzard
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

9.  A comparison of endogenous development of three isolates of Cryptosporidium in suckling mice.

Authors:  W L Current; N C Reese
Journal:  J Protozool       Date:  1986-02

Review 10.  Cryptosporidiosis in perspective.

Authors:  S Tzipori
Journal:  Adv Parasitol       Date:  1988       Impact factor: 3.870

View more
  22 in total

Review 1.  In vitro cultivation of cryptosporidium species.

Authors:  Michael J Arrowood
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

2.  In vitro determination of anticryptosporidial activity of phytogenic extracts and compounds.

Authors:  Klaus Teichmann; Maxime Kuliberda; Gerd Schatzmayr; Franz Hadacek; Anja Joachim
Journal:  Parasitol Res       Date:  2012-01-26       Impact factor: 2.289

3.  Sexual stage development of cryptosporidia in the Caco-2 cell line.

Authors:  M Buraud; E Forget; L Favennec; J Bizet; J G Gobert; A M Deluol
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

4.  Cyclosporin analogs inhibit in vitro growth of Cryptosporidium parvum.

Authors:  M E Perkins; T W Wu; S M Le Blancq
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

5.  Development and validation of a cell culture based assay for in vitro assessment of anticryptosporidial compounds.

Authors:  M Najdrowski; A R Heckeroth; C Wackwitz; S Gawlowska; U Mackenstedt; D Kliemt; A Daugschies
Journal:  Parasitol Res       Date:  2007-01-10       Impact factor: 2.289

6.  Analysis of oocyst wall and sporozoite antigens from three Cryptosporidium species.

Authors:  J M Nina; V McDonald; D A Dyson; J Catchpole; S Uni; M Iseki; P L Chiodini; K P McAdam
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR Swiss miceby polyether ionophores and aromatic amidines.

Authors:  B L Blagburn; C A Sundermann; D S Lindsay; J E Hall; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

8.  Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites.

Authors:  Dion A Kevin Ii; Damaris Af Meujo; Mark T Hamann
Journal:  Expert Opin Drug Discov       Date:  2009-02       Impact factor: 6.098

9.  Cdc42 and the actin-related protein/neural Wiskott-Aldrich syndrome protein network mediate cellular invasion by Cryptosporidium parvum.

Authors:  Xian-Ming Chen; Bing Q Huang; Patrick L Splinter; James D Orth; Daniel D Billadeau; Mark A McNiven; Nicholas F LaRusso
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 10.  Cryptosporidiosis.

Authors:  W L Current; L S Garcia
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.